Morgan Stanley’s BioTelemetry, Inc. BEAT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-288,793
| Closed | -$20.8M | – | 7730 |
|
|
2020
Q4 | $20.8M | Buy |
288,793
+82,086
| +40% | +$4.3M | ﹤0.01% | 1784 |
|
|
2020
Q3 | $9.42M | Buy |
206,707
+11,186
| +6% | +$468K | ﹤0.01% | 2081 |
|
|
2020
Q2 | $8.84M | Buy |
195,521
+8,090
| +4% | +$362K | ﹤0.01% | 2079 |
|
|
2020
Q1 | $7.22M | Sell |
187,431
-46,380
| -20% | -$2.14M | ﹤0.01% | 2086 |
|
|
2019
Q4 | $10.8M | Buy |
233,811
+52,099
| +29% | +$2.26M | ﹤0.01% | 2353 |
|
|
2019
Q3 | $7.4M | Sell |
181,712
-89,100
| -33% | -$3.85M | ﹤0.01% | 2442 |
|
|
2019
Q2 | $13M | Buy |
270,812
+135,663
| +100% | +$7.13M | ﹤0.01% | 1877 |
|
|
2019
Q1 | $8.46M | Sell |
135,149
-107,544
| -44% | -$7.39M | ﹤0.01% | 2195 |
|
|
2018
Q4 | $14.5M | Sell |
242,693
-30,921
| -11% | -$1.86M | ﹤0.01% | 1746 |
|
|
2018
Q3 | $17.6M | Buy |
273,614
+9,995
| +4% | +$558K | ﹤0.01% | 1813 |
|
|
2018
Q2 | $11.9M | Buy |
263,619
+131,375
| +99% | +$5.24M | ﹤0.01% | 2174 |
|
|
2018
Q1 | $4.11M | Sell |
132,244
-1,287
| -1% | -$42.3K | ﹤0.01% | 3237 |
|
|
2017
Q4 | $3.99M | Buy |
133,531
+48,701
| +57% | +$1.41M | ﹤0.01% | 3337 |
|
|
2017
Q3 | $2.8M | Buy |
84,830
+12,671
| +18% | +$439K | ﹤0.01% | 3552 |
|
|
2017
Q2 | $2.41M | Sell |
72,159
-88,233
| -55% | -$2.63M | ﹤0.01% | 3634 |
|
|
2017
Q1 | $4.64M | Buy |
160,392
+9,546
| +6% | +$236K | ﹤0.01% | 2929 |
|
|
2016
Q4 | $3.37M | Buy |
150,846
+56,803
| +60% | +$1.11M | ﹤0.01% | 3405 |
|
|
2016
Q3 | $1.75M | Sell |
94,043
-28,797
| -23% | -$543K | ﹤0.01% | 3601 |
|
|
2016
Q2 | $2M | Buy |
122,840
+107,656
| +709% | +$1.58M | ﹤0.01% | 3419 |
|
|
2016
Q1 | $178K | Sell |
15,184
-7,324
| -33% | -$81.8K | ﹤0.01% | 5046 |
|
|
2015
Q4 | $263K | Sell |
22,508
-170,877
| -88% | -$2.16M | ﹤0.01% | 4936 |
|
|
2015
Q3 | $2.37M | Buy |
193,385
+30,818
| +19% | +$393K | ﹤0.01% | 3353 |
|
|
2015
Q2 | $1.53M | Sell |
162,567
-155,386
| -49% | -$1.44M | ﹤0.01% | 3863 |
|
|
2015
Q1 | $2.81M | Sell |
317,953
-22,149
| -7% | -$224K | ﹤0.01% | 3260 |
|
|
2014
Q4 | $3.41M | Buy |
340,102
+150,063
| +79% | +$1.29M | ﹤0.01% | 3081 |
|
|
2014
Q3 | $1.28M | Sell |
190,039
-132,941
| -41% | -$932K | ﹤0.01% | 3823 |
|
|
2014
Q2 | $2.31M | Sell |
322,980
-394,017
| -55% | -$3.14M | ﹤0.01% | 3372 |
|
|
2014
Q1 | $7.23M | Buy |
716,997
+349,708
| +95% | +$3.22M | ﹤0.01% | 2224 |
|
|
2013
Q4 | $2.92M | Sell |
367,289
-168,077
| -31% | -$1.57M | ﹤0.01% | 3080 |
|
|
2013
Q3 | $5.3M | Buy |
535,366
+515,223
| +2,558% | +$4.06M | ﹤0.01% | 2376 |
|
|
2013
Q2 | $119K | Buy |
+20,143
| New | +$67.8K | ﹤0.01% | 5033 |
|
Other funds holding BEAT
Morgan Stanley's BEAT Position: Q1 2021 in Review
Morgan Stanley sold out of BioTelemetry, Inc. (BEAT) in Q1 2021, closing a stake of 288,793 shares — an estimated $20.8M sold.
Morgan Stanley first reported a position in BEAT in Q2 2013 and held it in 31 quarters. The position peaked at $20.8M in Q4 2020. 1 fund tracked by Wall St. Rank holds BEAT as of Q1 2021.
- Morgan Stanley reported no remaining BioTelemetry, Inc. position as of Q1 2021 after selling out during the quarter.
- Morgan Stanley sold 288,793 BioTelemetry, Inc. shares in Q1 2021, an estimated $20.8M.
- Morgan Stanley first reported a position in BioTelemetry, Inc. in Q2 2013 and held it in 31 quarters.
- Morgan Stanley's BioTelemetry, Inc. position peaked at $20.8M in Q4 2020.
- 1 fund tracked by Wall St. Rank held BioTelemetry, Inc. as of Q1 2021.
Based on Morgan Stanley's 13F filing for Q1 2021, filed 17 May 2021.